Animal NDC 58829-221-01 Bismusol

Bismuth Subsalicylate

Bismusol Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Otc - Purpose



Anti-Diarrheal Liquid
Palatable Oral Suspension


Otc - Keep Out Of Reach Of Children



For Animal Use Only • Keep Out of Reach of Children


Indications:



A palatable oral suspension for use as an aid in controlling simple diarrhea in cattle, horses, dogs and cats.


Caution:



This product contains salicylate; do not administer with other salicylate-containing products, such as aspirin. Do not administer to pregnant animals unless prescribed by a licensed veterinarian.


Dosage And Administration:



Administer orally.
Dogs and Cats - 1 to 3 tablespoonfuls every 1-3 hours.
Calves and Foals - 3 to 4 ounces every 2-3 hours.
Horses and Cattle - 6 to 10 ounces every 2-3 hours.


Active Ingredient:



Bismuth Subsalicylate .............. 1.75% w/w
In a palatable aqueous suspension. Flavoring and coloring added.


Inactive Ingredients:



Water, Xanthan Gum, Magnesium Salicylate, Methyl Salicylate, Sodium Saccharin, Hydrochloric Acid, Methylparaben, Propylparaben, and FD&C Red #40.


Warning:



If diarrhea persists after using this product for 2 days, consult veterinarian.


Storage:



Store at controlled room temperature between 15° to 30°C (59°-86°F). Keep container tightly closed when not in use.


Otc - When Using



SHAKE WELL BEFORE USING.
FOR ORAL USE ONLY.
KEEP FROM FREEZING.

Reorder No. MS120PC


Net Contents:



One Gallon (3.785 L) 


Information For Owners/Caregivers



Priority Care is a registered trademark of First Priority, Inc.

Made in U.S.A.

Manufactured By: FIRST PRIORITY, INC., Elgin, IL U.S.A.

www.prioritycare.com


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.